Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Feb 17, 2021 4:50pm
300 Views
Post# 32587947

Lets put today in context:

Lets put today in context:Yes there is a long histroy. So...we are here & now.
At any point & time, the decsion is the same. Buy/Hold or sell.

So what about "today's " information?

1. recent "buy recomendation from a large Wall street form @ $15 ) usd) = $19 CDN
2. premarket price & volume amazing numbers.
3. Traded 10X normal volume today, price spiked. WE know there is an incresed short position. We also know some lost $ today, some gained and some just started.
4. Two weeks ago, there was an institutional "buy" of $3 million. Probaly from the company A.T.M.

What about ONC itself?

1. They are about 10 trading days from year end & Q3 Confernce call.
2. They are in trials with Merck, Pfizer, B.M.S , Roche & Incyte ..all major pahrma 
3. They are expecting trial resutls/updates any time now, Some are long over-due.

Those items are all stright up fat boiled out facts.

Now some thoughts: If any one of the trials comes through, the price rating will be well above $20usd++
If a partnership of buy-out happens the price will be ??? above $25 USD minium.
 Now: forget the history it means nothing.
What does mean something is the shares you & I hold today, Now..
or are going to buy sometime , or sell.

based on these facts? Buy , Hold or sell?


( there is an alternate , selling some) etc etc.

ANyone shorting right now, is risking a whole bunch of $$$$

The downside? 
They need to come out with some very bad news. Even then will still be around $1 
Upside "unlimited"





<< Previous
Bullboard Posts
Next >>